GenomeNet

Database: UniProt
Entry: PDUA_SALTY
LinkDB: PDUA_SALTY
Original site: PDUA_SALTY 
ID   PDUA_SALTY              Reviewed;          94 AA.
AC   P0A1C7; P37448;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2005, sequence version 1.
DT   27-MAR-2024, entry version 90.
DE   RecName: Full=Bacterial microcompartment shell protein PduA {ECO:0000303|PubMed:11844753};
DE   AltName: Full=Bacterial microcompartment protein homohexamer {ECO:0000305};
DE            Short=BMC-H {ECO:0000303|PubMed:33227310};
DE   AltName: Full=Propanediol utilization protein PduA;
GN   Name=pduA {ECO:0000303|PubMed:8071226}; OrderedLocusNames=STM2038;
OS   Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Salmonella.
OX   NCBI_TaxID=99287;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=LT2;
RX   PubMed=8071226; DOI=10.1128/jb.176.17.5474-5482.1994;
RA   Chen P., Anderson D.I., Roth J.R.;
RT   "The control region of the pdu/cob regulon in Salmonella typhimurium.";
RL   J. Bacteriol. 176:5474-5482(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=LT2;
RX   PubMed=9352910; DOI=10.1128/jb.179.21.6633-6639.1997;
RA   Bobik T.A., Xu Y., Jeter R.M., Otto K.E., Roth J.R.;
RT   "Propanediol utilization genes (pdu) of Salmonella typhimurium: three genes
RT   for the propanediol dehydratase.";
RL   J. Bacteriol. 179:6633-6639(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=LT2 / SGSC1412 / ATCC 700720;
RX   PubMed=11677609; DOI=10.1038/35101614;
RA   McClelland M., Sanderson K.E., Spieth J., Clifton S.W., Latreille P.,
RA   Courtney L., Porwollik S., Ali J., Dante M., Du F., Hou S., Layman D.,
RA   Leonard S., Nguyen C., Scott K., Holmes A., Grewal N., Mulvaney E.,
RA   Ryan E., Sun H., Florea L., Miller W., Stoneking T., Nhan M., Waterston R.,
RA   Wilson R.K.;
RT   "Complete genome sequence of Salmonella enterica serovar Typhimurium LT2.";
RL   Nature 413:852-856(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PATHWAY, SEQUENCE REVISION TO
RP   C-TERMINUS, AND INDUCTION.
RC   STRAIN=LT2;
RX   PubMed=10498708; DOI=10.1128/jb.181.19.5967-5975.1999;
RA   Bobik T.A., Havemann G.D., Busch R.J., Williams D.S., Aldrich H.C.;
RT   "The propanediol utilization (pdu) operon of Salmonella enterica serovar
RT   typhimurium LT2 includes genes necessary for formation of polyhedral
RT   organelles involved in coenzyme B(12)-dependent 1, 2-propanediol
RT   degradation.";
RL   J. Bacteriol. 181:5967-5975(1999).
RN   [5]
RP   PROTEIN SEQUENCE OF 1-7, FUNCTION, AND SUBCELLULAR LOCATION.
RC   STRAIN=LT2;
RX   PubMed=12923081; DOI=10.1128/jb.185.17.5086-5095.2003;
RA   Havemann G.D., Bobik T.A.;
RT   "Protein content of polyhedral organelles involved in coenzyme B12-
RT   dependent degradation of 1,2-propanediol in Salmonella enterica serovar
RT   Typhimurium LT2.";
RL   J. Bacteriol. 185:5086-5095(2003).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=LT2;
RX   PubMed=11844753; DOI=10.1128/jb.184.5.1253-1261.2002;
RA   Havemann G.D., Sampson E.M., Bobik T.A.;
RT   "PduA is a shell protein of polyhedral organelles involved in coenzyme
RT   B(12)-dependent degradation of 1,2-propanediol in Salmonella enterica
RT   serovar typhimurium LT2.";
RL   J. Bacteriol. 184:1253-1261(2002).
RN   [7]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=LT2;
RX   PubMed=18296526; DOI=10.1128/jb.01925-07;
RA   Sampson E.M., Bobik T.A.;
RT   "Microcompartments for B12-dependent 1,2-propanediol degradation provide
RT   protection from DNA and cellular damage by a reactive metabolic
RT   intermediate.";
RL   J. Bacteriol. 190:2966-2971(2008).
RN   [8]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=LT2;
RX   PubMed=21239588; DOI=10.1128/jb.01473-10;
RA   Cheng S., Sinha S., Fan C., Liu Y., Bobik T.A.;
RT   "Genetic analysis of the protein shell of the microcompartments involved in
RT   coenzyme B12-dependent 1,2-propanediol degradation by Salmonella.";
RL   J. Bacteriol. 193:1385-1392(2011).
RN   [9]
RP   FUNCTION, INTERACTION WITH PDUP, DOMAIN, AND MUTAGENESIS OF 81-HIS--SER-93;
RP   HIS-81; VAL-84 AND LEU-88.
RC   STRAIN=LT2;
RX   PubMed=22927404; DOI=10.1073/pnas.1207516109;
RA   Fan C., Cheng S., Sinha S., Bobik T.A.;
RT   "Interactions between the termini of lumen enzymes and shell proteins
RT   mediate enzyme encapsulation into bacterial microcompartments.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:14995-15000(2012).
RN   [10]
RP   BIOTECHNOLOGY (ARTIFICIAL BMCS).
RC   STRAIN=LT2;
RX   PubMed=24014666; DOI=10.1099/mic.0.069922-0;
RA   Sargent F., Davidson F.A., Kelly C.L., Binny R., Christodoulides N.,
RA   Gibson D., Johansson E., Kozyrska K., Lado L.L., MacCallum J., Montague R.,
RA   Ortmann B., Owen R., Coulthurst S.J., Dupuy L., Prescott A.R., Palmer T.;
RT   "A synthetic system for expression of components of a bacterial
RT   microcompartment.";
RL   Microbiology 159:2427-2436(2013).
RN   [11]
RP   MODELING OF BMCS, FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=25646976; DOI=10.1371/journal.pcbi.1004067;
RA   Jorda J., Liu Y., Bobik T.A., Yeates T.O.;
RT   "Exploring bacterial organelle interactomes: a model of the protein-protein
RT   interaction network in the Pdu microcompartment.";
RL   PLoS Comput. Biol. 11:e1004067-e1004067(2015).
RN   [12]
RP   FUNCTION, AND INDUCTION.
RC   STRAIN=LT2;
RX   PubMed=26283792; DOI=10.1074/jbc.m115.651919;
RA   Jakobson C.M., Kim E.Y., Slininger M.F., Chien A., Tullman-Ercek D.;
RT   "Localization of proteins to the 1,2-propanediol utilization
RT   microcompartment by non-native signal sequences is mediated by a common
RT   hydrophobic motif.";
RL   J. Biol. Chem. 290:24519-24533(2015).
RN   [13]
RP   SUBCELLULAR LOCATION.
RC   STRAIN=LT2;
RX   PubMed=27063436; DOI=10.1038/srep24359;
RA   Held M., Kolb A., Perdue S., Hsu S.Y., Bloch S.E., Quin M.B.,
RA   Schmidt-Dannert C.;
RT   "Engineering formation of multiple recombinant Eut protein nanocompartments
RT   in E. coli.";
RL   Sci. Rep. 6:24359-24359(2016).
RN   [14]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF SER-40.
RC   STRAIN=LT2;
RX   PubMed=27561553; DOI=10.1111/mmi.13423;
RA   Chowdhury C., Chun S., Sawaya M.R., Yeates T.O., Bobik T.A.;
RT   "The function of the PduJ microcompartment shell protein is determined by
RT   the genomic position of its encoding gene.";
RL   Mol. Microbiol. 101:770-783(2016).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF
RP   LYS-26 AND LYS-37.
RC   STRAIN=LT2;
RX   PubMed=28585808; DOI=10.1021/acssynbio.7b00042;
RA   Slininger Lee M.F., Jakobson C.M., Tullman-Ercek D.;
RT   "Evidence for Improved Encapsulated Pathway Behavior in a Bacterial
RT   Microcompartment through Shell Protein Engineering.";
RL   ACS Synth. Biol. 6:1880-1891(2017).
RN   [16]
RP   FUNCTION IN METABOLITE DIFFUSION.
RC   STRAIN=LT2;
RX   PubMed=28829618; DOI=10.1021/acs.jpcb.7b07232;
RA   Park J., Chun S., Bobik T.A., Houk K.N., Yeates T.O.;
RT   "Molecular Dynamics Simulations of Selective Metabolite Transport across
RT   the Propanediol Bacterial Microcompartment Shell.";
RL   J. Phys. Chem. B 121:8149-8154(2017).
RN   [17]
RP   SYSTEM-MODELING, AND FUNCTION.
RC   STRAIN=LT2;
RX   PubMed=28475631; DOI=10.1371/journal.pcbi.1005525;
RA   Jakobson C.M., Tullman-Ercek D., Slininger M.F., Mangan N.M.;
RT   "A systems-level model reveals that 1,2-Propanediol utilization
RT   microcompartments enhance pathway flux through intermediate
RT   sequestration.";
RL   PLoS Comput. Biol. 13:e1005525-e1005525(2017).
RN   [18]
RP   BIOTECHNOLOGY (FORMING PROTEIN SHELLS), AND MUTAGENESIS OF LYS-26.
RC   STRAIN=LT2;
RX   PubMed=31845931; DOI=10.1039/c9tb02224d;
RA   Bari N.K., Kumar G., Hazra J.P., Kaur S., Sinha S.;
RT   "Functional protein shells fabricated from the self-assembling protein
RT   sheets of prokaryotic organelles.";
RL   J. Mater. Chem. B 8:523-533(2020).
RN   [19]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF LYS-26.
RC   STRAIN=LT2;
RX   PubMed=33227310; DOI=10.1016/j.jmb.2020.11.020;
RA   Kennedy N.W., Ikonomova S.P., Slininger Lee M., Raeder H.W.,
RA   Tullman-Ercek D.;
RT   "Self-assembling Shell Proteins PduA and PduJ have Essential and Redundant
RT   Roles in Bacterial Microcompartment Assembly.";
RL   J. Mol. Biol. 433:166721-166721(2021).
RN   [20] {ECO:0007744|PDB:3NGK}
RP   X-RAY CRYSTALLOGRAPHY (2.26 ANGSTROMS) OF 2-94, FUNCTION, AND SUBUNIT.
RC   STRAIN=LT2;
RX   PubMed=20870711; DOI=10.1074/jbc.m110.160580;
RA   Crowley C.S., Cascio D., Sawaya M.R., Kopstein J.S., Bobik T.A.,
RA   Yeates T.O.;
RT   "Structural insight into the mechanisms of transport across the Salmonella
RT   enterica Pdu microcompartment shell.";
RL   J. Biol. Chem. 285:37838-37846(2010).
RN   [21] {ECO:0007744|PDB:4PPD}
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 2-94, FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-26; ASN-29; LYS-37; LYS-55 AND
RP   ARG-79.
RC   STRAIN=LT2;
RX   PubMed=24747050; DOI=10.1016/j.jmb.2014.04.012;
RA   Sinha S., Cheng S., Sung Y.W., McNamara D.E., Sawaya M.R., Yeates T.O.,
RA   Bobik T.A.;
RT   "Alanine scanning mutagenesis identifies an asparagine-arginine-lysine
RT   triad essential to assembly of the shell of the Pdu microcompartment.";
RL   J. Mol. Biol. 426:2328-2345(2014).
RN   [22] {ECO:0007744|PDB:4QIE}
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 2-94, AND SUBUNIT.
RA   Pang A.H., Sawaya M.R., Bobik T.A., Yeates T.O.;
RT   "Crystal Structure of PduA with edge mutation K26D.";
RL   Submitted (MAY-2014) to the PDB data bank.
RN   [23] {ECO:0007744|PDB:4QIF, ECO:0007744|PDB:4QIG, ECO:0007744|PDB:4RBT, ECO:0007744|PDB:4RBU, ECO:0007744|PDB:4RBV}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2-94, FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF SER-40.
RC   STRAIN=LT2;
RX   PubMed=25713376; DOI=10.1073/pnas.1423672112;
RA   Chowdhury C., Chun S., Pang A., Sawaya M.R., Sinha S., Yeates T.O.,
RA   Bobik T.A.;
RT   "Selective molecular transport through the protein shell of a bacterial
RT   microcompartment organelle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:2990-2995(2015).
CC   -!- FUNCTION: One of the major shell proteins of the bacterial
CC       microcompartment (BMC) dedicated to 1,2-propanediol (1,2-PD)
CC       degradation (PubMed:11844753, PubMed:21239588) (Probable). At least one
CC       of PduA or PduJ is required for BMC assembly; it must be encoded as the
CC       first gene in the pdu operon (PubMed:33227310, PubMed:27561553). Not
CC       required for structural integrity of BMCs, it is required to mitigate
CC       propionaldehyde toxicity (PubMed:21239588). Controls diffusion of 1,2-
CC       PD into and propionaldehyde out of the BMC shell; residue 40 is
CC       particularly important for pore permeability (PubMed:28585808,
CC       PubMed:25713376, PubMed:27561553) (Probable). Overexpression of this
CC       protein leads to aberrant filaments that extend the length of the cell,
CC       cross the cleavage furrow and impair division. The filaments form
CC       nanotubes with a hollow center (PubMed:11844753, PubMed:33227310). The
CC       isolated BMC shell component protein ratio for J:A:B':B:K:T:U is
CC       approximately 15:10:7:6:1:1:2 (PubMed:12923081). Edge residues
CC       (particularly Lys-26) are important for function and assembly of the
CC       BMC, and influence array formation by hexamers (PubMed:24747050).
CC       Interaction with PduA allows encapsulation of at least PduP in BMCs
CC       (PubMed:22927404). Probably also targets PduD to the BMC (Probable).
CC       PduA is probably the hub for binding multiple enzymes to the interior
CC       of the BMC; modeling suggests PduC, PduD, PduE, PduG, PduL and PduP are
CC       targeted to PduA (Probable). {ECO:0000269|PubMed:11844753,
CC       ECO:0000269|PubMed:12923081, ECO:0000269|PubMed:21239588,
CC       ECO:0000269|PubMed:22927404, ECO:0000269|PubMed:24747050,
CC       ECO:0000269|PubMed:25713376, ECO:0000269|PubMed:27561553,
CC       ECO:0000269|PubMed:28585808, ECO:0000269|PubMed:33227310,
CC       ECO:0000305|PubMed:20870711, ECO:0000305|PubMed:24747050,
CC       ECO:0000305|PubMed:25646976, ECO:0000305|PubMed:26283792,
CC       ECO:0000305|PubMed:28829618}.
CC   -!- FUNCTION: The 1,2-PD-specific bacterial microcompartment (BMC)
CC       concentrates low levels of 1,2-PD catabolic enzymes, concentrates
CC       volatile reaction intermediates thus enhancing pathway flux and keeps
CC       the level of toxic, mutagenic propionaldehyde low.
CC       {ECO:0000269|PubMed:18296526, ECO:0000269|PubMed:25713376,
CC       ECO:0000305|PubMed:28475631}.
CC   -!- PATHWAY: Polyol metabolism; 1,2-propanediol degradation.
CC       {ECO:0000305|PubMed:10498708}.
CC   -!- SUBUNIT: Homohexamer with a central pore of about 5.6 Angstroms in
CC       diameter. The hexamers pack against each other in arrays
CC       (PubMed:20870711, PubMed:24747050, Ref.22, PubMed:25713376). Interacts
CC       with the N-terminus of PduP which targets PduP to the BMC
CC       (PubMed:22927404). Modeling suggests PduC, PduD, PduE, PduL and PduP
CC       interact with a cleft formed by the C-terminal segments of 2 adjacent
CC       PduA subunits (on the BMC luminal side) in the hexamer (Probable).
CC       {ECO:0000269|PubMed:20870711, ECO:0000269|PubMed:22927404,
CC       ECO:0000269|PubMed:24747050, ECO:0000269|PubMed:25713376,
CC       ECO:0000269|Ref.22, ECO:0000305|PubMed:25646976}.
CC   -!- SUBCELLULAR LOCATION: Bacterial microcompartment
CC       {ECO:0000269|PubMed:11844753, ECO:0000269|PubMed:12923081,
CC       ECO:0000269|PubMed:24747050, ECO:0000269|PubMed:25713376,
CC       ECO:0000269|PubMed:27063436, ECO:0000269|PubMed:28585808}. Note=The C-
CC       terminus probably faces the interior of the BMC (Probable). Modeling
CC       suggests the concave face (with both termini) is in the interior of the
CC       BMC (Probable). {ECO:0000305|PubMed:22927404,
CC       ECO:0000305|PubMed:25646976}.
CC   -!- INDUCTION: The first gene in the pdu operon. BMC production is induced
CC       by growth on 1,2-PD vitamin B12 medium (PubMed:10498708,
CC       PubMed:26283792). No change when grown in the presence of 1,2-PD,
CC       ethanolamine and vitamin B12, suggesting it is possible for both the
CC       eut and pdu operons to be expressed at the same time (PubMed:26283792).
CC       {ECO:0000269|PubMed:10498708, ECO:0000269|PubMed:26283792}.
CC   -!- DOMAIN: The C-terminal 14 residues mediate binding to the N-terminus of
CC       PduP, which encapsulates PduP into BMCs. {ECO:0000269|PubMed:22927404}.
CC   -!- DISRUPTION PHENOTYPE: Cells do not make BMCs, diol dehydratase is found
CC       in diffuse aggregates near the cell pole; it was later found this a
CC       double pduA-pduBB' deletion (PubMed:11844753). A single deletion forms
CC       larger than normal BMCs; it is not fully complemented by protein
CC       produced from a plasmid (PubMed:21239588, PubMed:27561553). Grows in an
CC       interrupted manner on 1,2-PD and vitamin B12; grows for a while then
CC       stops, then restarts as toxic propionaldehyde accumulates and then
CC       decreases (PubMed:11844753, PubMed:28585808, PubMed:21239588,
CC       PubMed:18296526, PubMed:33227310). Increased DNA mutagenesis, showing
CC       propionaldehyde is a mutagen (PubMed:18296526). Makes slightly larger
CC       BMCs; this phenotype can be rescued by PduA, but PduJ encoded on a
CC       plasmid cannot rescue a PduA deletion. When pduJ is cloned in the
CC       chromosomal position of pduA it substantially rescues the pduA deletion
CC       (PubMed:27561553, PubMed:33227310). Single pduA deletion makes BMCs but
CC       a double pduA-pduJ deletion does not (PubMed:33227310).
CC       {ECO:0000269|PubMed:11844753, ECO:0000269|PubMed:18296526,
CC       ECO:0000269|PubMed:21239588, ECO:0000269|PubMed:27561553,
CC       ECO:0000269|PubMed:28585808, ECO:0000269|PubMed:33227310}.
CC   -!- BIOTECHNOLOGY: Artificial BMCs can be made in E.coli by expressing
CC       pduA-pduB/B'-pduT-pduU-pduN-pduJ-pduK (in this order). Enzymes can be
CC       targeted to the BMC, and appear to be encapsulated within it.
CC       {ECO:0000269|PubMed:24014666}.
CC   -!- BIOTECHNOLOGY: Upon overexpression and mixing of purified sheets with
CC       2-ethyl-1-hexanol, will form closed shells. Enzymes (tested with
CC       endogenous BMC enzyme DDH and the peroxidase activity of cytC) can be
CC       encapsulated in the shells; the enzyme is active in the shells. The
CC       shells are permeable to a variety of compounds, showing they could be
CC       used to make protein based synthetic bioreactors.
CC       {ECO:0000269|PubMed:31845931}.
CC   -!- MISCELLANEOUS: Bacterial microcompartments (BMC) 100-200 nm in cross
CC       section are formed during aerobic growth on minimal 1,2-PD-B12 or
CC       anaerobic growth on 1,2-PD-tetrathionate medium, but not during aerobic
CC       growth on glucose, anerobic growth on glucose or pyruvate-tetrathionate
CC       (PubMed:10498708). BMCs can constitute up to 10% of total cell protein
CC       (PubMed:12923081). {ECO:0000269|PubMed:10498708,
CC       ECO:0000269|PubMed:12923081}.
CC   -!- SIMILARITY: Belongs to the bacterial microcompartments protein family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01278}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF026270; AAB84107.2; -; Genomic_DNA.
DR   EMBL; AE006468; AAL20942.1; -; Genomic_DNA.
DR   RefSeq; NP_460983.1; NC_003197.2.
DR   RefSeq; WP_001183618.1; NC_003197.2.
DR   PDB; 3NGK; X-ray; 2.26 A; A=2-94.
DR   PDB; 4PPD; X-ray; 2.40 A; A/B/C/D/E/F/G=2-94.
DR   PDB; 4QIE; X-ray; 2.35 A; A/B/C/D/E/F/G/H/I=2-94.
DR   PDB; 4QIF; X-ray; 2.00 A; A/B/C/D/E/F/G/H/I=2-94.
DR   PDB; 4QIG; X-ray; 3.30 A; A/B/C/D/E/F/G=2-94.
DR   PDB; 4RBT; X-ray; 2.30 A; A/B/C=2-94.
DR   PDB; 4RBU; X-ray; 2.79 A; A/B/C/D/E/F/G/H/I=2-94.
DR   PDB; 4RBV; X-ray; 3.10 A; A/B/C/D/E/F/G=2-94.
DR   PDBsum; 3NGK; -.
DR   PDBsum; 4PPD; -.
DR   PDBsum; 4QIE; -.
DR   PDBsum; 4QIF; -.
DR   PDBsum; 4QIG; -.
DR   PDBsum; 4RBT; -.
DR   PDBsum; 4RBU; -.
DR   PDBsum; 4RBV; -.
DR   AlphaFoldDB; P0A1C7; -.
DR   SMR; P0A1C7; -.
DR   STRING; 99287.STM2038; -.
DR   TCDB; 1.S.1.1.1; the bacterial microcompartment shell/pore-forming protein-1 (bmc-sp1) family.
DR   PaxDb; 99287-STM2038; -.
DR   GeneID; 1253559; -.
DR   GeneID; 77226968; -.
DR   KEGG; stm:STM2038; -.
DR   PATRIC; fig|99287.12.peg.2160; -.
DR   HOGENOM; CLU_064903_5_3_6; -.
DR   OMA; HSEVEMI; -.
DR   PhylomeDB; P0A1C7; -.
DR   BioCyc; SENT99287:STM2038-MONOMER; -.
DR   UniPathway; UPA00621; -.
DR   Proteomes; UP000001014; Chromosome.
DR   GO; GO:0031472; C:propanediol degradation polyhedral organelle; IDA:UniProtKB.
DR   GO; GO:0051144; P:propanediol catabolic process; IEA:UniProtKB-UniPathway.
DR   CDD; cd07045; BMC_CcmK_like; 1.
DR   Gene3D; 3.30.70.1710; -; 1.
DR   InterPro; IPR020808; Bact_microcomp_CS.
DR   InterPro; IPR000249; BMC_dom.
DR   InterPro; IPR037233; CcmK-like_sf.
DR   InterPro; IPR044872; CcmK/CsoS1_BMC.
DR   PANTHER; PTHR33941:SF11; BACTERIAL MICROCOMPARTMENT SHELL PROTEIN PDUJ; 1.
DR   PANTHER; PTHR33941; PROPANEDIOL UTILIZATION PROTEIN PDUA; 1.
DR   Pfam; PF00936; BMC; 1.
DR   SMART; SM00877; BMC; 1.
DR   SUPFAM; SSF143414; CcmK-like; 1.
DR   PROSITE; PS01139; BMC_1; 1.
DR   PROSITE; PS51930; BMC_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Bacterial microcompartment; Direct protein sequencing;
KW   Reference proteome; Transport.
FT   CHAIN           1..94
FT                   /note="Bacterial microcompartment shell protein PduA"
FT                   /id="PRO_0000201511"
FT   DOMAIN          5..89
FT                   /note="BMC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01278"
FT   MUTAGEN         26
FT                   /note="K->A: No BMCs are made, forms hexamers which do not
FT                   form arrays, dominant to wild-type protein. Little to no
FT                   growth on 1,2-PD, cells elongate and are joined by
FT                   filaments, BMC proteins aggregate near poles. No longer
FT                   forms filaments upon overexpression, does not restore BMC
FT                   formation to a double pduA-pduJ deletion. Does not form
FT                   closed shells."
FT                   /evidence="ECO:0000269|PubMed:24747050,
FT                   ECO:0000269|PubMed:28585808, ECO:0000269|PubMed:31845931,
FT                   ECO:0000269|PubMed:33227310"
FT   MUTAGEN         29
FT                   /note="N->A: Subject to propionaldehyde toxicity, makes
FT                   about 75% BMCs, shells are wrinkled and leaky."
FT                   /evidence="ECO:0000269|PubMed:24747050"
FT   MUTAGEN         37
FT                   /note="K->A: Slow growth at limiting vitamin B12, wild-type
FT                   at saturating conditions."
FT                   /evidence="ECO:0000269|PubMed:24747050"
FT   MUTAGEN         37
FT                   /note="K->Q: Improved growth on 1,2-PD, makes slightly
FT                   larger BMCs, alters accumulation of PD metabolites."
FT                   /evidence="ECO:0000269|PubMed:28585808"
FT   MUTAGEN         40
FT                   /note="S->A: No change in shell permeability to PD,
FT                   excretes more propionaldehyde, wild-type growth on 1,2-PD."
FT                   /evidence="ECO:0000269|PubMed:25713376"
FT   MUTAGEN         40
FT                   /note="S->C: Crystallized, central pore can be open or
FT                   occluded, less permeable to substrate, cells grow slowly on
FT                   1,2-PD."
FT                   /evidence="ECO:0000269|PubMed:25713376"
FT   MUTAGEN         40
FT                   /note="S->GSG: Crystallized, central pore is occluded, less
FT                   permeable to PD, 62% DDH activity, cells grow slowly on
FT                   1,2-PD."
FT                   /evidence="ECO:0000269|PubMed:25713376"
FT   MUTAGEN         40
FT                   /note="S->H: Crystallized, central pore is less symmetric,
FT                   no change in shell permeability, increased permeability to
FT                   glycerol, wild-type growth on 1,2-PD."
FT                   /evidence="ECO:0000269|PubMed:25713376"
FT   MUTAGEN         40
FT                   /note="S->L: Crystallized, central pore is more hydrophobic
FT                   but same size, less permeable to PD, 50% DDH activity,
FT                   cells grow slowly on 1,2-PD."
FT                   /evidence="ECO:0000269|PubMed:25713376,
FT                   ECO:0000269|PubMed:27561553"
FT   MUTAGEN         40
FT                   /note="S->M: No change in shell permeability, wild-type
FT                   growth on 1,2-PD."
FT                   /evidence="ECO:0000269|PubMed:25713376"
FT   MUTAGEN         40
FT                   /note="S->Q: Crystallized, central pore is occluded, less
FT                   permeable to substrate, 75% DDH activity, cells grow slowly
FT                   on 1,2-PD."
FT                   /evidence="ECO:0000269|PubMed:25713376"
FT   MUTAGEN         40
FT                   /note="S->T: No change in shell permeability, wild-type
FT                   growth on 1,2-PD."
FT                   /evidence="ECO:0000269|PubMed:25713376"
FT   MUTAGEN         55
FT                   /note="K->A: Slow growth at limiting vitamin B12, wild-type
FT                   at saturating conditions."
FT                   /evidence="ECO:0000269|PubMed:24747050"
FT   MUTAGEN         79
FT                   /note="R->A: Subject to propionaldehyde toxicity, makes
FT                   about 70% BMCs, protein shells appear wild-type but leak."
FT                   /evidence="ECO:0000269|PubMed:24747050"
FT   MUTAGEN         81..93
FT                   /note="Missing: No longer interacts with PduP."
FT                   /evidence="ECO:0000269|PubMed:22927404"
FT   MUTAGEN         81
FT                   /note="H->A: Decreased amounts of PduP in purified BMCs."
FT                   /evidence="ECO:0000269|PubMed:22927404"
FT   MUTAGEN         84
FT                   /note="V->A: Decreased amounts of PduP in purified BMCs."
FT                   /evidence="ECO:0000269|PubMed:22927404"
FT   MUTAGEN         88
FT                   /note="L->A: Decreased amounts of PduP in purified BMCs."
FT                   /evidence="ECO:0000269|PubMed:22927404"
FT   STRAND          4..13
FT                   /evidence="ECO:0007829|PDB:4QIF"
FT   HELIX           14..24
FT                   /evidence="ECO:0007829|PDB:4QIF"
FT   STRAND          30..39
FT                   /evidence="ECO:0007829|PDB:4QIF"
FT   STRAND          42..50
FT                   /evidence="ECO:0007829|PDB:4QIF"
FT   HELIX           51..66
FT                   /evidence="ECO:0007829|PDB:4QIF"
FT   STRAND          69..78
FT                   /evidence="ECO:0007829|PDB:4QIF"
FT   TURN            82..87
FT                   /evidence="ECO:0007829|PDB:4QIF"
SQ   SEQUENCE   94 AA;  9592 MW;  5EDC7C793F19DE1E CRC64;
     MQQEALGMVE TKGLTAAIEA ADAMVKSANV MLVGYEKIGS GLVTVIVRGD VGAVKAATDA
     GAAAARNVGE VKAVHVIPRP HTDVEKILPK GISQ
//
DBGET integrated database retrieval system